세계의 3D 메디컬 이미징 시장 : 컴포넌트, 기술, 모달리티, 용도, 최종 사용자별 예측(2025-2030년)

The 3D Medical Imaging Market was valued at USD 17.88 billion in 2023, expected to reach USD 19.64 billion in 2024, and is projected to grow at a CAGR of 9.92%, to USD 34.68 billion by 2030.

3D medical imaging is an advanced technology that constructs a three-dimensional visualization of the internal structures of a body, enabling more precise diagnostics and improving patient care. Its necessity is underscored by the increasing prevalence of chronic diseases and the need for detailed anatomical models in surgical planning. Applications span radiology, oncology, cardiology, and orthopedics, with end-users including hospitals, diagnostic centers, and research institutes. The demand for minimally invasive diagnosis, advancements in imaging modalities, and integration with AI technology are critical growth factors driving market expansion. The aging global population and rising cases of complex diseases further bolster this demand. Recent advances in machine learning and AI provide potential opportunities for innovation, as they can improve image accuracy, reduce diagnosis time, and enhance patient throughput. Emphasis on portable imaging solutions and personalized medicine are areas ripe for research and business development. However, challenges such as high initial costs, stringent regulatory requirements, and a shortage of skilled professionals can stymie growth. Additionally, the complexity of data management and privacy concerns over patient information remain pertinent issues. To capitalize on emerging opportunities, firms should invest in AI-driven technology to enhance imaging accuracy and efficiency. Collaborations with tech companies to develop user-friendly software could address skill shortages. Exploring teleradiology could extend market reach, while compliance with GDPR and other data protection regulations will be vital. As an inherently innovative sector, the 3D medical imaging market remains dynamic, with continual advancements opening new pathways for research and growth. By addressing current limitations through strategic partnerships and technological innovations, businesses can maintain competitive advantage and propel forward in an evolving landscape characterized by technological convergence and digital transformation.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving 3D Medical Imaging Market

The 3D Medical Imaging Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of chronic diseases necessitating advanced imaging for accurate diagnosis
  • Rising adoption of minimally invasive procedures across the healthcare sector
  • Growing geriatric population globally increasing the demand for diagnostic imaging
• Market Restraints
  • High cost associated with development and maintenance of 3D imaging systems
• Market Opportunities
  • Increasing investments in artificial intelligence from 3D imaging companies
  • Rising demand for point-of-care imaging coupled with growing population
• Market Challenges
  • Stringent regulatory requirements and complex approval procedures for medical imaging systems

Porter's Five Forces: A Strategic Tool for Navigating the 3D Medical Imaging Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the 3D Medical Imaging Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the 3D Medical Imaging Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the 3D Medical Imaging Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the 3D Medical Imaging Market

A detailed market share analysis in the 3D Medical Imaging Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the 3D Medical Imaging Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the 3D Medical Imaging Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the 3D Medical Imaging Market

A strategic analysis of the 3D Medical Imaging Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the 3D Medical Imaging Market, highlighting leading vendors and their innovative profiles. These include Analogic Corporation, Autodesk, Inc., Barco NV, Bruker Corporation, Canon Medical Systems Corporation, Del Medical, Inc., DigiRad Corporation, Esaote SpA, FARO Technologies, Inc., FUJIFILM Holdings Corporation, GE HealthCare Technologies Inc., Hitachi Medical Corporation, Hologic, Inc., iCAD, Inc., Intrasense SA, Konica Minolta, Inc., Koninklijke Philips N.V, Materialise NV, Mindray Medical International Limited, Neusoft Medical Systems Co. Ltd., Planmed Oy, Shimadzu Corporation, Siemens AG, STMicroelectronics N.V., TeraRecon, Inc., and Trivitron Healthcare.

Market Segmentation & Coverage

This research report categorizes the 3D Medical Imaging Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Component, market is studied across Hardware, Services, and Software. The Hardware is further studied across Imaging Devices and Scanners. The Software is further studied across Imaging software and Picture Archiving and Communication System.
• Based on Technology, market is studied across Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Nuclear Imaging, Ultrasound, and X-ray.
• Based on Modality, market is studied across Portable and Stationary.
• Based on Application, market is studied across Cardiology, Dentistry, Neurology, Obstetrics & Gynecology, Oncology, and Orthopedics.
• Based on End-User, market is studied across Ambulatory Surgical Centers, Diagnostic Imaging Centers, Hospitals, and Research and Academic Institutions.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of chronic diseases necessitating advanced imaging for accurate diagnosis
    • 5.1.1.2. Rising adoption of minimally invasive procedures across the healthcare sector
    • 5.1.1.3. Growing geriatric population globally increasing the demand for diagnostic imaging
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with development and maintenance of 3D imaging systems
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing investments in artificial intelligence from 3D imaging companies
    • 5.1.3.2. Rising demand for point-of-care imaging coupled with growing population
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory requirements and complex approval procedures for medical imaging systems
• 5.2. Market Segmentation Analysis
  • 5.2.1. Component: Growing preference for 3D imaging software for advanced functionalities
  • 5.2.2. Application: Revolutionary advancements in AI-enhanced 3D medical imaging drive transformative impacts across cardiology and dentistry
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. 3D Medical Imaging Market, by Component

• 6.1. Introduction
• 6.2. Hardware
  • 6.2.1. Imaging Devices
  • 6.2.2. Scanners
• 6.3. Services
• 6.4. Software
  • 6.4.1. Imaging software
  • 6.4.2. Picture Archiving and Communication System

7. 3D Medical Imaging Market, by Technology

• 7.1. Introduction
• 7.2. Computed Tomography (CT)
• 7.3. Magnetic Resonance Imaging (MRI)
• 7.4. Nuclear Imaging
• 7.5. Ultrasound
• 7.6. X-ray

8. 3D Medical Imaging Market, by Modality

• 8.1. Introduction
• 8.2. Portable
• 8.3. Stationary

9. 3D Medical Imaging Market, by Application

• 9.1. Introduction
• 9.2. Cardiology
• 9.3. Dentistry
• 9.4. Neurology
• 9.5. Obstetrics & Gynecology
• 9.6. Oncology
• 9.7. Orthopedics

10. 3D Medical Imaging Market, by End-User

• 10.1. Introduction
• 10.2. Ambulatory Surgical Centers
• 10.3. Diagnostic Imaging Centers
• 10.4. Hospitals
• 10.5. Research and Academic Institutions

11. Americas 3D Medical Imaging Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific 3D Medical Imaging Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa 3D Medical Imaging Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Fujifilm launches Innovative 3D lung navigation system enhancing bronchoscopy
  • 14.3.2. Philips Healthcare launches Azurion neuro biplane system with advanced 3D imaging and AI innovations
  • 14.3.3. HoloCare launches advanced 3D surgical hologram tech in Europe and UK
  • 14.3.4. Karl Storz acquires Innersight Labs to enhance 3D medical imaging with AI
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Analogic Corporation
• 2. Autodesk, Inc.
• 3. Barco NV
• 4. Bruker Corporation
• 5. Canon Medical Systems Corporation
• 6. Del Medical, Inc.
• 7. DigiRad Corporation
• 8. Esaote SpA
• 9. FARO Technologies, Inc.
• 10. FUJIFILM Holdings Corporation
• 11. GE HealthCare Technologies Inc.
• 12. Hitachi Medical Corporation
• 13. Hologic, Inc.
• 14. iCAD, Inc.
• 15. Intrasense SA
• 16. Konica Minolta, Inc.
• 17. Koninklijke Philips N.V
• 18. Materialise NV
• 19. Mindray Medical International Limited
• 20. Neusoft Medical Systems Co. Ltd.
• 21. Planmed Oy
• 22. Shimadzu Corporation
• 23. Siemens AG
• 24. STMicroelectronics N.V.
• 25. TeraRecon, Inc.
• 26. Trivitron Healthcare